Home » Shop » hot sale » Phospho-AKT (Ser473) Antibody

Phospho-AKT (Ser473) Antibody

Original price was: $118.40.Current price is: $88.26.

Sale!
SKU: PW14836858193 Category:

Phospho-AKT (Ser473) Antibody

Catalog number: B2016020
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 50 g
Molecular Weight or Concentration: N/A
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -20 C
Keywords: Phospho-AKT (Ser473) Antibody
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Malik SN, Brattain M, Ghosh PM, Troyer DA, Prihoda T, Bedolla R, Kreisberg JI. Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer Clin Cancer Res. 2002 Apr;8(4):1168-71.
  • Seow HF, Yip WK, Loh HW, Ithnin H, Por P, Rohaizak M. Immunohistochemical detection of phospho-Akt, phospho-BAD, HER2 and oestrogen receptors alpha and beta in Malaysian breast cancer patients Pathol Oncol Res. 2010 Jun;16(2):239-48.
  • Varela-M RE, Ochoa R, Muskus CE, Muro A, Mollinedo F. Identification of a RAC/AKT-like gene in Leishmania parasites as a putative therapeutic target in leishmaniasis Parasit Vectors. 2017 Oct 10;10(1):458.
  • Kim JJ, Liang W, Kang CC, Pegram MD, Herr AE. Single-cell immunoblotting resolves estrogen receptor- isoforms in breast cancer PLoS One. 2021 Jul 27;16(7):e0254783.
  • Hammarsten P, Cipriano M, Josefsson A, Stattin P, Egevad L, Granfors T, Fowler CJ. Phospho-Akt immunoreactivity in prostate cancer: relationship to disease severity and outcome, Ki67 and phosphorylated EGFR expression PLoS One. 2012;7(10):e47994.
  • Zhao S, Fu J, Liu X, Wang T, Zhang J, Zhao Y. Activation of Akt/GSK-3beta/beta-catenin signaling pathway is involved in survival of neurons after traumatic brain injury in rats Neurol Res. 2012 May;34(4):400-7.
  • Altomare DA, Wang HQ, Skele KL, De Rienzo A, Klein-Szanto AJ, Godwin AK, Testa JR. AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth Oncogene. 2004 Jul 29;23(34):5853-7.
  • Ramezani S, Vousooghi N, Ramezani Kapourchali F, Joghataei MT. Perifosine enhances bevacizumab-induced apoptosis and therapeutic efficacy by targeting PI3K/AKT pathway in a glioblastoma heterotopic model Apoptosis. 2017 Aug;22(8):1025-1034.
  • Prez-lvarez MJ, Maza Mdel C, Anton M, Ordoez L, Wandosell F. Post-ischemic estradiol treatment reduced glial response and triggers distinct cortical and hippocampal signaling in a rat model of cerebral ischemia J Neuroinflammation. 2012 Jul 2;9:157.